1. Home
  2. EYPT vs LEGH Comparison

EYPT vs LEGH Comparison

Compare EYPT & LEGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EYPT
  • LEGH
  • Stock Information
  • Founded
  • EYPT 1987
  • LEGH 2005
  • Country
  • EYPT United States
  • LEGH United States
  • Employees
  • EYPT N/A
  • LEGH N/A
  • Industry
  • EYPT Biotechnology: Laboratory Analytical Instruments
  • LEGH Homebuilding
  • Sector
  • EYPT Industrials
  • LEGH Consumer Discretionary
  • Exchange
  • EYPT Nasdaq
  • LEGH Nasdaq
  • Market Cap
  • EYPT 579.4M
  • LEGH 588.8M
  • IPO Year
  • EYPT 2005
  • LEGH 2018
  • Fundamental
  • Price
  • EYPT $9.55
  • LEGH $23.43
  • Analyst Decision
  • EYPT Strong Buy
  • LEGH Strong Buy
  • Analyst Count
  • EYPT 8
  • LEGH 2
  • Target Price
  • EYPT $24.75
  • LEGH $29.00
  • AVG Volume (30 Days)
  • EYPT 841.7K
  • LEGH 105.1K
  • Earning Date
  • EYPT 08-06-2025
  • LEGH 08-07-2025
  • Dividend Yield
  • EYPT N/A
  • LEGH N/A
  • EPS Growth
  • EYPT N/A
  • LEGH 8.04
  • EPS
  • EYPT N/A
  • LEGH 2.29
  • Revenue
  • EYPT $56,042,000.00
  • LEGH $176,618,000.00
  • Revenue This Year
  • EYPT N/A
  • LEGH N/A
  • Revenue Next Year
  • EYPT N/A
  • LEGH $8.23
  • P/E Ratio
  • EYPT N/A
  • LEGH $10.36
  • Revenue Growth
  • EYPT 12.04
  • LEGH N/A
  • 52 Week Low
  • EYPT $3.91
  • LEGH $21.58
  • 52 Week High
  • EYPT $13.99
  • LEGH $29.31
  • Technical
  • Relative Strength Index (RSI)
  • EYPT 61.03
  • LEGH 59.31
  • Support Level
  • EYPT $7.94
  • LEGH $21.91
  • Resistance Level
  • EYPT $10.77
  • LEGH $22.99
  • Average True Range (ATR)
  • EYPT 0.76
  • LEGH 0.65
  • MACD
  • EYPT -0.01
  • LEGH 0.19
  • Stochastic Oscillator
  • EYPT 56.89
  • LEGH 73.41

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

About LEGH Legacy Housing Corporation (TX)

Legacy Housing Corp builds, sell, and finance manufactured homes and tiny houses that are distributed through a network of independent retailers and company-owned stores and also sold directly to manufactured home communities. The company also provides financing options to its customers to facilitate the sale of homes.

Share on Social Networks: